Symposium:
206. Mano-a-Mano Controversies in Pediatric ID
Saturday, October 10, 2015: 10:30 AM-12:00 PM
Room: 6--CF

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss benefits and drawbacks of different empiric antibiotic regimens for treating febrile infants
  • debate benefits and drawback of different options for treating Methicillin-Susceptible Staphylococcus aureus infections
  • describe benefits and drawbacks of Oseltamivir treatment for children with influenza

Target Audience: Pharmacists, Members-in-training, Infectious diseases physicians, Infectious diseases pediatricians, Healthcare workers, Fellows, Clinicians, Academicians

Tracks: Trainee, Pediatric ID

Moderators:  Ravi Jhaveri, MD, FIDSA, FPIDS, University of North Carolina School of Medicine and Natasha Halasa, MD, MPH, FPIDS, Vanderbilt University

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-198-L01-P

Disclosures:

R. Jhaveri, MedImmune: Grant Investigator , Research grant
Merck: Grant Investigator , Research grant
Genentech: Scientific Advisor , Consulting fee
GenMark: Grant Investigator , Grant recipient

N. Halasa, Sanofi Pasteur: Grant Investigator , Grant recipient , Research grant and Research support
Gilead: Grant Investigator , Research support
Pfizer: Grant Investigator , Grant recipient , Research grant and Research support
Baxter: Grant Investigator , Grant recipient , Research grant and Research support
Biocryst: Grant Investigator , Research support

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.